ANIKA VAUGHN-COOKE: Open Payments
NPI 1376779470 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,019 in 78 payments from 12 companies in 2025. Trend: 2023 $903 · 2024 $1,147 · 2025 $2,019
Food & beverage: $1,920Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $384 |
| Neurocrine BioSciences, Inc. | 11 | $358 |
| Teva Pharmaceuticals USA, Inc. | 11 | $322 |
| ABBVIE INC. | 12 | $247 |
| Alkermes, Inc. | 8 | $186 |
| E.R. Squibb & Sons, L.L.C. | 6 | $143 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $109 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Lundbeck LLC | 2 | $47 |
Products named: INVEGA SUSTENNA, INGREZZA, VRAYLAR, UZEDY, ARISTADA, REXULTI, COBENFY, CAPLYTA.
Industry payments across PA — which companies pay providers there.
